Having completed a 5-year term of research in March 2012, the centre embarked on a new 5-year phase in April 2012. Our purpose is to support and grow “translational research” so that advances achieved in basic medical research can be tested for safety and benefit to patients – and, where successful, ultimately be introduced nationwide as substantiated improvements in treatment, diagnosis and management of people with eye diseases.
Our site is one of 11 Biomedical Research Centres (BRCs) in England and the only one solely dedicated to vision. Funding from the Department of Health is awarded through the NIHR to NHS and University partnerships which have an outstanding track record for medical research and expertise and experience of translating research into a clinical setting. Our BRC was awarded £26.5 million for our 5-year term.
The Moorfields Eye Hospital/UCL Institute of Ophthalmology partnership has a strong track record of basic biomedical research, much of which has led to translational programmes and innovations that have already benefited large numbers of patients in the United Kingdom and around the world.
The juxtaposition of a huge and unique clinical resource at Moorfields with over 500,000 patient visits per year, together with one of the largest and most productive eye research institutions with over 45 academic staff, has led to a wide range of ground-breaking biomedical research firmly embedded in an appreciation of patients’ needs.
To find out more please go to www.brcophthalmology.org
Sight Loss and Vision Priority Setting Partnership Results
The Sight Loss and Vision Priority Setting Partnership Survey in 2012 asked patients, carers and eye health professionals to identify unanswered questions about the prevention, diagnosis and treatment of sight loss and eye conditions that they wished to see answered. 2,220 people responded to the survey generating 4,461 questions.
The questions were checked and both duplicates and those not relating to sight loss and vision were removed. Those remaining were then allocated to 12 different eye disease/condition categories and similar submissions were combined.
At workshops held in April and May 2013 the top priorities for each category were agreed.
To find out more information please download report